Clinical Trial Update: OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update indicates the investigational agent OMO-103 is being studied in an early-phase trial for locally advanced or metastatic pancreatic ductal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• OMO-103

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma | EARLY_Phase 1 | Status: RECRUITING